- Adults
- Outpatient clinic
- Community
- Primary care
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Immunomodulator
- Colchicine
- Metformin
Intervention: Pharmacological intervention
This refers to the drug, therapy, or factor being studied in a clinical trial or observational study. Examples include antiviral agents monoclonal antibodies, corticosteroids, vaccines and other pharmacological agents
- Adults
- General population
- Elderly
- Paediatric
- Outpatient clinic
- Arbovirus
- Dengue virus
- Vector-borne disease
- Arboviral disease
- Vector-borne disease
- Blood sample
- Pharmacological intervention
- Vaccination
- Qdenga
- Adults
- Elderly
- People at high risk of STIs
- Men who have sex with men
- PrEP users
- Non-hospital health centre
- STD/STI clinic
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Mycoplasma genitalium
- Hepatitis
- HIV
- Treponema pallidum
- Sexually transmitted infection
- Anal-rectal swab
- Oral swab
- Urethral exudate
- Pharmacological intervention
- PrEP-HIV
- Adults
- Elderly
- People at high risk of STIs
- Men who have sex with men
- PrEP users
- Primary care
- Non-hospital health centre
- STD/STI clinic
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Syphilis
- Sexually transmitted infection
- Pharmacological intervention
- Antivirals
- PrEP-HIV
- Adults
- Elderly
- People at high risk of STIs
- PrEP users
- Hospital wide
- Community
- Primary care
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Syphilis
- Sexually transmitted infection
- Pharmacological intervention
- PrEP-bSTI
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Adults
- General population
- Outpatient clinic
- Community
- Primary care
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- vasodilator
- Vericiguat
- Adults
- General population
- Elderly
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Anti-depressant
- Tianeptine
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Plitidepsin
- Antineoplastic agent
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Pycnogenol
- Adults
- Elderly
- Fragile population
- Infectious diseases unit
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Monoclonal antibodies
- Tixagevimab/Cilgavimab
- Elderly
- Fragile population
- Outpatient clinic
- Community
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Molnupiravir